We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Study Shows Climbing Fatality Rate for SARS

By HospiMedica staff writers
Posted on 13 May 2003
An epidemiologic study conducted by UK epidemiologists and scientists from Hong Kong reveals a much higher mortality rate for severe acute respiratory syndrome (SARS) than initially reported, especially among older patients. More...
The study was published in the May 7, 2003, online issue of The Lancet.

The researchers studied 1,425 cases from Hong Kong. They found that the fatality rate in patients 60 and older was 43.3%, far higher than previously reported. In patients under 60, the rate was 13.2%. Using a second method of calculation, these numbers were 55% and 6.8%, respectively. The average incubation period was found to be 6.4 days.

The study underscored the importance of reducing the time from onset of symptoms to quarantining in a hospital, which reduces transmission. Public health interventions resulted in a significant reduction in confirmed SARS cases. These interventions included encouraging patients to report to a hospital rapidly after onset of symptoms, tracing contacts of confirmed and suspected cases and quarantining them, and restricting the travel of contacts.

In The Lancet article, co-author Christl Donnelly comments, "Although this study shows that the fatality rate from SARS is higher than previously thought, we now know that public-health interventions have been successfully reducing the spread of the disease.” The study was conducted by Dr. Donnelly, Dr. Roy Anderson, and colleagues from Imperial College (London, UK) and the Department of Health in Hong Kong.


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.